Literature DB >> 2157343

The significance of epithelial differentiation in mixed mesodermal tumors of the uterus. A clinicopathologic and immunohistochemical study.

P Bitterman1, B Chun, R J Kurman.   

Abstract

Mixed mesodermal tumors and carcinosarcomas of the uterus are classified as sarcomas. However, in other sites, malignant biphasic tumors may be classified as carcinomas, mesotheliomas, or sarcomas. In order to clarify their behavior and patterns of differentiation, we performed a clinicopathologic and immunohistochemical study of 22 cases aimed at analyzing the pattern of spread and histologic appearance of the metastasis, as well as the distribution of intermediate filaments in the primary tumor and the metastasis. Four monoclonal antibodies (Mabs) were used to detect epithelial lineage, three that recognize keratin (AE1/AE3, CAM5.2, MAK6) and one that recognizes epithelial membrane antigen (EMA). A Mab against vimentin was also used. Metastases involved the omentum, pelvic peritoneum, ovaries, fallopian tubes, pelvic or para-aortic lymph nodes, liver parenchyma, and tonsil. These metastases were composed of carcinoma only. Lymphatic/vascular invasion was identified in 11 cases; it consisted exclusively of carcinoma. In all 12 cases evaluated immunohistochemically, keratin and EMA were identified in the majority of the cells in the epithelial component and in a more focal distribution in the spindle cell component in 11 (92%). Vimentin was detected in the majority of spindle cells in nine cases (75%) and in a more focal distribution in the epithelial component in six cases (50%). In the spindle cell component, keratin and EMA were present in widely scattered individual spindle-shaped and rounded cells, within solid clusters of rounded cells, and in nests of cells with small lumens. The distribution of keratin, EMA, and vimentin in the metastases (carcinoma in all instances) was similar to the epithelial component in the primary tumor. Our findings indicate that the epithelial component of these tumors invades lymphatic/vascular spaces and metastasizes, whereas the spindle cell component has limited metastatic potential, if any. Since the behavior of these neoplasms is dictated by the epithelial element, we believe that mixed mesodermal tumors of the uterus should be classified as carcinomas rather than sarcomas.

Entities:  

Mesh:

Year:  1990        PMID: 2157343     DOI: 10.1097/00000478-199004000-00002

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.

Authors:  Matthieu Le Gallo; Meghan L Rudd; Mary Ellen Urick; Nancy F Hansen; Maria J Merino; David G Mutch; Paul J Goodfellow; James C Mullikin; Daphne W Bell
Journal:  Cancer       Date:  2017-09-21       Impact factor: 6.860

Review 2.  Malignant biphasic uterine tumours: carcinosarcomas or metaplastic carcinomas?

Authors:  W G McCluggage
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

3.  Lineage-restricted clonality in biphasic solid tumors.

Authors:  J A Fletcher; G S Pinkus; N Weidner; C C Morton
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

4.  Tissue microarray analysis of hormonal signaling pathways in uterine carcinosarcoma.

Authors:  Gloria S Huang; Rebecca C Arend; Maomi Li; Marc J Gunter; Lydia G Chiu; Susan Band Horwitz; Gary L Goldberg
Journal:  Am J Obstet Gynecol       Date:  2009-02-06       Impact factor: 8.661

5.  Carcinosarcoma of the uterus-a single institution retrospective analysis of the management and outcome and a brief review of literature.

Authors:  Rajanbabu Anupama; Santhosh Kuriakose; D K Vijaykumar; K Pavithran; Annie Jojo; R Nair Indu; V S Sheejamol
Journal:  Indian J Surg Oncol       Date:  2013-01-27

6.  Urinary bladder leiomyosarcoma in adults.

Authors:  Apostolos P Labanaris; Vahudin Zugor; Bernd Meyer; Reinhold Nützel; Stephan Helmus; Panagiotis G Labanaris; Reinhard Kühn
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

7.  Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

Authors:  R F Caduff; C M Johnston; T S Frank
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

8.  Brain Metastasis in a Young Patient with Uterine Carcinosarcoma.

Authors:  Vatsala Katiyar; Tiago Araujo; Muhammad Z Farooq; Ishaan Vohra; Shweta Gupta
Journal:  Cureus       Date:  2019-06-26

9.  Chemotherapeutic management of recurrent/metastatic uterine carcinosarcomas (malignant mixed mullerian tumors): time for a re-appraisal?

Authors:  Maurie Markman
Journal:  J Cancer Res Clin Oncol       Date:  2004-08-05       Impact factor: 4.553

10.  Topography of epithelial-mesenchymal plasticity.

Authors:  Francesc Font-Clos; Stefano Zapperi; Caterina A M La Porta
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-21       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.